Purpose CAPE (caffeic acid phenethyl ester) is one of the most valuable and investigated component of propolis which is composed by honeybees. In the current study, we aimed at examining apoptotic effects of CAPE on CCRF-CEM leukemic cells and at determining the roles of mitochondrial membrane potential (MMP) in cell death. Methods Trypan blue and XTT methods were used to evaluate the cytotoxicity. Apoptosis was examined by ELISA-based oligonucleotide and acridine orange/ethidium bromide dye techniques. Loss of mitochondrial membrane potential was evaluated using JC-1 dye by flow cytometric analysis and under fluorescent microscope. Results We detected the time-and dose-dependent increases in cytotoxic effect of CAPE on CCRF-CEM cells. ELISA and acridine orange/ethidium bromide results showed that apoptotic cell population increased significantly in CCRF-CEM cells exposed to increasing concentrations of CAPE. On the other hand, there was significant loss of MMP determined in response to CAPE in CCRF-CEM cells.
Introduction
Acute lymphoblastic leukemia (ALL) is a hematological malignancy resulting from clonal proliferation of early B-and T-lymphocyte progenitors. It is characterized by increased accumulation of leukemic blast cells in bone marrow and extramedullary sites. Although high rates of hematological responses obtained from the current treatment protocols in the vast majority of patients, the emergence of resistance to applied anticancer agents decreases the efficiency of treatment (Crazzolara and Bendall 1999) . Having poor outcomes, short-term survival rates, and serious side effects in response to chemotherapeutic agents in patients with ALL imposed basic science researchers and clinicians to investigate novel anticancer agents derived from the natural sources, such as plants, animals, and sea products. Likewise, the numbers of studies investigating the anticancer potential of natural products have been increasing significantly.
CAPE is a chemical and structural relative of flavanoids and an active component of propolis. It has antiviral, antiinflammatory, immunomodulatory, and antiproliferative effects in different conditions. Antiproliferative ability of CAPE has been considered as a new anticancer treatment modality and has been studied in many cancers and cell lines both in vivo and in vitro (Crazzolara and Bendall 1999; Borrelli et al. 2002; Son and Lewis 2002; Lee et al. 2000; Demestre et al. 2009 ). Several studies reported that the antitumoral effect of CAPE was possibly related to the alteration of redox potentials resulting in apoptosis, suppression of lipid peroxidation, inhibition of ornithine decarboxylase, and protein synthesis, and inhibition of activation of nuclear factor kappa B (NF-jB; Li et al. 2000; Berger et al. 1992; Rao et al. 1992; Michaluart et al. 1999; Sud'ina et al. 1993; Fesen et al. 1994) . Interestingly, it was also shown that CAPE exerts apoptotic effect and suppresses the growth of transformed cells in a specific manner (Chiao et al. 1995) . However, the apoptotic effects of CAPE on CCRF-CEM acute lymphoblastic leukemia cells and, if so, the roles of mitochondrial membrane potential in programmed cell death are not investigated previously.
Mitochondria have a central role in cellular functions in both normal and cancerous cells. The impact of mitochondrial activities on cellular physiology is not only restricted to ATP supply, but also to generate reactive oxygen species (ROS), to regulate intracellular Ca 2? homeostasis, and more importantly to regulate apoptosis through cytochrome c release (Gogvadze et al. 2008) . Once the cytosolic effectors of apoptosis are activated, loss of mitochondrial membrane potential takes place, and cytochrome c and some other proteins are released from the intermembrane space of mitochondria to cytoplasm. This process activates caspases and downstream targets resulting in apoptosis . Since the statues of mitochondria during the glycolytic pathways are essential for the survival of cancer cells, strategies targeting the mitochondria may provide an important avenue for the treatment of various types of cancers. In fact, there are different chemotherapeutic agents that can specifically alter the mitochondrial membrane potential (Gogvadze et al. 2008; Wolvetang et al. 1994; Asoh et al. 1996; Schmidt-Mende et al. 2006; Neuzil et al. 2001 Neuzil et al. , 2006 Neuzil et al. , 2007 Yu et al. 2003) .
In the present study, we aimed at investigating the possible cytotoxic and apoptotic effects of CAPE on CCRF-CEM leukemic cells and at clarifying the involvement of the changes in mitochondrial membrane potential in this apoptotic process.
Materials and methods

Cell line and chemicals
Human T-cell acute lymphoblastic leukemia cells (CCRF-CEM) were obtained from ECACC (UK, No: 85112105) . CAPE was obtained from Sigma Chemical (LM, USA). 200 lM stock solution of CAPE was prepared and dissolved in dimethylsulfoxide (DMSO), and the final concentration of DMSO has never been more than 0.1% in the experiments. Trypan blue dye was obtained from Biological Industries (Israel). MitoProbe JC-1 Assay Kit was obtained from Invitrogen (CA, USA). XTT Cell Proliferation Assay was obtained from Roche Diagnostics (Munchen, Germany). All the other chemicals and tissue culture supplies were obtained from Sigma (Deisenhofen, Germany) unless otherwise specified.
Evaluation of cytotoxicity CCRF-CEM cell line grown in RPMI-1640 medium containing 2 mM L-glutamine supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin was maintained at a density of 5 9 10 5 cells/ml in a standard cell culture incubator at 37°C, 100% relative humidity, and 5% CO 2 atmosphere (Sahin et al. 2007 ). Prior to any experiment, cells were split at 5 9 10 5 cells/ml in the RPMI 1640 medium, and cell suspensions were aliquoted into flasks for subsequent treatments. CAPE diluted in RPMI 1640 was used in treatments of 1 nM, 10 nM, 100 nM, 1 lM, 10 lM, and 100 lM.
Cytotoxic assays and determination of IC 50 (drug concentration that inhibits cell proliferation 50% when compared to untreated controls) dose of CAPE in CCRF-CEM cells were performed by using Trypan blue dye exclusion and XTT assay as indicated in manufacturer's instruction.
Cytotoxicity of CAPE by XTT-based cytotoxicity assay was determined as follows:
Cells were seeded in 96-well tissue culture plates and incubated for 24 h without drug. After addition of drug, cells were incubated for 96 h, and cell viability was assessed by using XTT-PMS mixture (XTT sodium salt; [2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt], phenazine methosulfate (N-methylphenazonium methyl sulfate salt)], as recommended by supplier. Formazan formation was quantified spectrophotometrically at 490 nM using a microplate reader (Bio-Rad, Coda, Richmond, CA).
Evaluation of apoptosis
Apoptosis was evaluated using Cell Death Detection ELISA assay (Roche Diagnostics, USA), and acridine orange/ethidium bromide method under fluorescence microscope. CAPE-induced apoptosis of CCRF-CEM cells was evaluated by using Cell Death Detection ELISA PLUS assay according to manufacturer's instructions. Briefly, untreated control and CAPE-treated cells were processed and analyzed for cytotoxic histone-bound DNA fragments. CCRF-CEM cells were exposed to 10 lM CAPE for 24, 48, 72, and 96 h. Changes in apoptosis rate were illustrated as the apoptotic index increased over the untreated control group. The absorbance, proportional to the degree of cell viability, was determined after addition of 2,2 0 -azino-di [3-ethylbenzthiozolin-sulfonate] , as substrate at 15 min by ELISA reader (Bio-Rad-Coda, Hercules, CA, USA) at 595 nm. The apoptosis level was calculated by the formula A s /A o , where A s represents the experimental sample absorbance, and A o represents the average absorbance produced in the assay using lysate from untreated cells. Apoptotic levels of control cells at each time point were defined as 1.0. In addition, apoptosis was also determined morphologically after staining with acridine orange/ethidium bromide by fluorescence microscopy. Briefly, the cells were washed with cold 19 PBS and adjusted to the cell density of 1 9 10 6 cells/ml in 19 PBS. Acridine orange and ethidium bromide (1:1, v/v) were added to the cell suspension in final concentrations of 100 lg/ml. After 30-min incubation of the cells, the cellular morphology was evaluated by fluorescence microscopy (Olympus, Japan). Apoptotic cells were essentially characterized by nuclear condensation of chromatin and/or nuclear fragmentation. Three hundred cells were evaluated for apoptosis and/or necrosis for each sample. When more than 50% of the pre-apoptotic plus apoptotic to total cell ratio was positive, the result was accepted positive for apoptosis.
Evaluation of mitochondrial membrane potential using JC-1 by flow cytometry and florescence microscope Loss of the mitochondrial membrane potential was detected by using MitoProbe TM JC-1 Assay Kit by flow cytometry (Invitrogen, OG, USA). JC-1 (5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 ,tetraethylbenzimidazolocarbocyanine iodide) has been widely used as a probe for cytofluorimetric analysis of the mitochondrial membrane potential. In apoptotic cells, JC-1 enters the cytoplasm as a monomer, emitting 527 nm (green fluorescence) after excitation at 490 nm, but in healthy cells it is taken up by the mitochondria, the lipophilic cationic dye accumulates within the negatively charged, hyperpolarized mitochondrial matrix, and forms JC-1 aggregates that emit at 590 nm (red fluorescence; Cossarizza et al. 1993) . Apoptotic cells were illustrated by the increase in green/red ratio evaluated by either fluorescence microscope or flow cytometry (Salvioli et al. 1997; Baran et al. 2007a; Swerts et al. 2004) .
In order to assess the integrity of the mitochondrial membrane, 1 9 10 6 CCRF-CEM cells treated with CAPE were suspended in 1 ml of warm media. The cells were labeled with 10 ll of JC-1 (200 lM) and incubated at 37°C, 5% CO 2 for 30 min. Excess amount of dye was removed by washing with 19 PBS. Pelleted cells were resuspended in 19 PBS and analyzed via flow cytometer with excitation wavelength of 480 nm, using appropriate emission filters for Alexa Fluor 488 dye and R-phytoerythrin. The changes in mitochondrial membrane potential in these cells were also analyzed under fluorescence microscope.
Statistical analysis
Statistical analyses were conducted using SPSS statistical package program. Non-linear regression analyses were used for the relationships between different variables. Student's t test was used to compare the means. P values \0.05 were considered statistically significant.
Results
Effects of CAPE on proliferation and viability of human CCRF-CEM cells
We have shown antiproliferative effects of CAPE on CCRF-CEM cells by both XTT cell proliferation and trypan blue dye exclusion assays. The results showed that there were dose-and time-dependent decreases in cell proliferation and viability when compared to untreated controls.
There were 43, 49, 56, and 60% decreases in cell proliferation in CCRF-CEM cells exposed to 10 lM CAPE for 24, 48, 72, and 96 h, respectively, compare to untreated controls (Fig. 1) . On the other hand, we have observed 10, 21, and 56% decreases in cell proliferation exposed to 0.1, 1, and 10 lM CAPE for 72 h.
We conducted the same set of experiments in order to determine the cell viabilities by trypan blue assay. The viability assay results were in agreement with cytotoxicity analyses and revealed the dose-and time-dependent decreases in viability of CCRF-CEM cells in response to CAPE. As shown in Fig. 2 , viable CCRF-CEM cell population were 65, 59, 13, and 3% in 10 lM CAPE-treated and 24, 48, 72, and 96 h incubated cells, respectively, when compared to untreated controls (Fig. 2) . The application of 
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24 h 48 h 72 h 96 h Fig. 1 Effects of CAPE on the growth of CCRF-CEM cells. The IC50 concentration of CAPE was calculated from cell proliferation plots. The XTT assays were performed using triplicate samples in at least two independent experiments. Statistical significance was determined using Student's t test, and (P \ 0.05) was considered significant J Cancer Res Clin Oncol (2011) 137:41-47 43 0.1, 1, and 10 lM CAPE for 72 h resulted in 85, 79, and 13% viability in CCRF-CEM cells.
Effect of CAPE treatment on early and late apoptosis in CCRF-CEM cells
In order to examine apoptotic effects of CAPE on CCRF-CEM cells, the cells were exposed to 10 lM CAPE for 24, 48, 72, and 96 h, and both early and late apoptosis were evaluated by using Cell Death Detection ELISA PLUS assay. In parallel with the previous data, the results revealed that there were time-dependent increases in apoptotic cells. About 5, 6, 29, and 39% of CCRF-CEM cell population were in early apoptosis in response to 10 lM CAPE for 24, 48, 72, and 96 h, respectively. Late apoptotic cell population in response to 10 lM CAPE in CCRF-CEM cells for the same periods of time were determined to be 0, 21, 30, and 25%, respectively (Fig. 3) .
Changes in apoptotic index in response to CAPE in CCRF-CEM cells
We evaluated apoptosis by Cell Death Detection ELISA assay. As shown in Fig. 4 , the results revealed that there were 1.24-, 1.39-, 1.18-, 1.18-fold increases in apoptotic index in CCRF-CEM cells treated with 10 lM CAPE for 24, 48, 72, and 96 h when compared to untreated controls (Fig. 4) .
Loss of mitochondrial membrane potential in CCRF-CEM cells exposed to CAPE Changes in mitochondrial membrane potential in CAPEapplied CCRF-CEM cells were observed under fluorescence microscope and determined by flow cytometry.
Under fluorescence microscope, we observed that application of 10 lM CAPE resulted in significant accumulation of JC-1 dye in cytoplasm when compared to untreated controls (Fig. 5) . Treatment of CCRF-CEM cells with 10 lM CAPE resulted in cell death as detected by flow cytometry. There were 29, 45, and 22% increases in death CCRF-CEM cell population in response to 10 lM CAPE for 24, 48, and 72 h, respectively, when compared to untreated controls (Fig. 6 ).
Discussion
The numbers of chemotherapeutic agents extracted from natural sources for the treatment of various types of cancers have been increasing recently. Complications related to chemical drugs forced scientists to develop novel treatment agents for cancer. Drugs originating from plants are strong potential agents not only since they have strong antitumor properties but also because they do not have any harmful Fig. 2 Effects of CAPE on the viability of CCRF-CEM cells. Trypan blue dye exclusion assays were performed using triplicate samples in at least two independent experiments. Statistical significance was determined using Student's t test, and (P \ 0.05) was considered significant Changes in apoptotic index in CCRF-CEM cells exposed to CAAPE. Statistical significance was determined using Student's t test, and P \ 0.05 was considered significant effects on normal healthy cells (Cassileth et al. 2008; Engdal et al. 2009 ). Recently, caffeic acid phenethyl ester (CAPE), obtained from honeybee propolis (Grunberger et al. 1998) , has attracted notice in that it represented antitumoral (Chiao et al. 1995) , anti-inflammatory (Michaluart et al. 1999; Orban et al. 2000) , antiviral (Fesen et al. 1994) , antioxidant (Bhimani et al. 1993) , and anti-angiogenic (Liao et al. 1999) effects. Although the ability of CAPE to induce apoptosis has been reported for various types of cancer, very little is known about the effects of CAPE on human CCRF-CEM cells (Michaluart et al. 1999; Fesen et al. 1994; Chiao et al. 1995; Grunberger et al. 1998; Orban et al. 2000; Bhimani et al. 1993; Liao et al. 1999) .
We conducted this study to examine whether CAPE has cytotoxic and apoptotic effects on CCRF-CEM cells and, if so, to investigate the mechanisms involved in cell death. The results of XTT cell proliferation and trypan blue viability assays revealed that CAPE has decreased proliferation and viability of CCRF-CEM cells in a dose-and time-dependent manner. On the other hand, in agreement with these results, apoptosis assay results also showed a dose-and time-dependent increases in apoptotic cell population in response to CAPE when compared to untreated controls. Flow cytometry and fluorescence microscope results revealed that CAPE induces apoptosis through induction of mitochondrial dysfunction, as demonstrated by the loss of mitochondrial membrane potential. It is very well known in the literature that apoptosis can be triggered by many internal and external stimuli, but mitochondria (mitochondrial membrane potential) are a common intersection point for all apoptotic pathways. As the numbers of permeability transition pores are increased which results in decreases in mitochondrial depolarization and release of calcium, caspase are activated and apoptosis is triggered. Thus, many internal and external stress generating factors result in the loss of mitochondrial membrane potential. Induction of apoptosis through loss of mitochondrial membrane potential was previously shown in K562 and Meg-01 chronic myeloid leukemia cells in response to imatinib, in acute lymphoblastic cells in response to resveratrol, in T-lymphoma cells in response to genistein, in HL60 cells in response to Hoechst 33342, and in acute lymphoblastic leukemia cells in response to resveratrol (Baran et al. 2007b, c; Zunino and Storms 2006; Baxa et al. 2005; Chen et al. 2004) .
In agreement with our results, it was recently shown by two different groups that CAPE induces apoptosis in human U937 myeloid leukemia cells through mitochondrial pathway but not through death receptors or ER-mediated apoptosis (Dörrie et al. 2001) . Chen et al. (2008) have shown that CAPE induced a time-dependent increase in apoptotic cell population through mitochondrial dysfunction in human BcPC-3 pancreatic cancer cells. The same group has also showed the loss of mitochondrial membrane potential to about half of the untreated level in response to CAPE only after 6 h in HL60 cells (Chen et al. 2001) . It was reported by several groups that CAPE inhibited cell growth and proliferation and triggered apoptosis in SW480 and HCT116 colorectal cancer cells, ME180 cervical cancer cells, C6 glioma cells, and MCF-7 breast cancer cell (He et al. 2006; Wang et al. 2005; Hung et al. 2003; Lee et al. 2003; Watabe et al. 2004; Burke et al. 1995) . On other hand, it was shown by Chung and his coworkers that besides inhibition of cell proliferation, CAPE also has inhibitory effects on invasion and metastasis through suppression of MMP-9 enzyme and downregulation of expression of NF-KB (Chung et al. 2004 ). CAPE has also been shown to have cell cycle arrest and DNA, RNA, and protein inhibition ability on HL60 cells (Chen et al. 1996) . Interestingly, several studies showed that CAPE has no cytotoxic and apoptotic effects on normal healthy cells (Lee et al. 2003) . It was shown in 2005 that CAPE application increased sensitivity of CT26 colorectal adenocarcinoma cells to ionizing radiation in BALB/c mouse while showed no cytotoxic effects on bone marrow, kidney, and liver (Chen et al. 2005) . These studies suggest that CAPE has cytotoxic effects only on malignant cells.
In conclusion, we have demonstrated for the first time that human CCRF-CEM acute lymphoblastic leukemia cells exposed to increasing concentrations of CAPE undergo apoptosis in a time-and dose-dependent manner. While the complete mechanism is not clear, we have shown by this study that CAPE-induced apoptosis at least involves loss of mitochondrial membrane potential which activates caspases. Taken together, these results may suggest that active component of propolis, CAPE, may have chemotherapeutic potential for the treatment of human acute lymphoblastic leukemia by inducing apoptosis. However, clinical outcomes of CAPE application remain to be examined before its use in clinics.
